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CHAPTER I 
Introduction 
Babesia species are tick-transmitted protozoan blood parasites that infect 
numerous vertebrates worldwide. Infections are characterized by a regenerative 
hemolytic anemia, anorexia, depression, multi-organ dysfunction, and occasionally 
death. Throughout the world, canine babesiosis occurs as the result of infection with 
either the "large" Babesia spp., B. canis, or a "small" Babesia spp., B. gibson i .. In the 
United States, B. canis is the most frequently reported species. With a single exception 
(Anderson et ai., 1979), B. gibsoni was not known to occur in North America until the 
1990s when reports were documented from California (Conrad et at., 1991; Yamane et 
ai., 1994; Wozniak et aI., 1997) and various midwestern and eastern states (Birkenheuer 
et aI., 1999; Irizarry-Rovira et aI., 2001; Kocan et aI., 2001; Macintire et aI., 2002). 
Recent genetic analysis of the entire 18S nuclear subunit ribosomal RNA gene of all 
known isolates ofB. gibsoni demonstrated that there are in fact not one, but three 
genetically distinct small canine Babesia spp. parasites, at least two ofwhich occur in 
the United States (Kjemtrup et at., 2000; Zahler et'at., 2000a; Zahler et ai., 2000b). 
These three isolates are the originally discovered Asian B. gibsoni isolate found in the 
midwestern and eastern United States, an isolate found in California and an isolate 
found in Spain. In North America, B. gibsoni sensu stricto has been reported 
predominantly in the American Staffordshire Terrier CAST) and appears to be 
maintained within breeding colonies through mechanical blood transfer and possibly 
-- -----------,-.:;-­
vertical transmission (Abu et at. 1973; Correa, 1974; Irizarry-Rovira et aI., 2001). 
Currently, there are no phannacological agents available that are effective in clearing 
the parasite from infected dogs. It is speculated that the sudden increase ofB. gibsoni 
cases in the United States is the result of importation of infected dogs from endemic 
locations outside ofNorth America such as Okinawa, Japan (Farwell et aI., 1982). 
Infected domestic dogs remain carriers ofB. gibsoni, therefore they not only 
increase the risk of spreading the disease to other dogs, but also pose a potential risk to 
wild canids where the impact of infection is unknown. Although naturally occurring B. 
gibsoni infections in wild canids have not been reported in the United States, it is 
known that interspecies interactions of domestic and wild canids occur through both 
natural and man-made conditions (Mengel, 1971; Freeman and Shaw, 1979; Schmitz 
and Kolenosky, 1985). 
The purpose of this study was to determine if coyotes from Oklahoma were 
susceptible to experimental infection with B. gibsoni and to then compare the clinical 
course of disease in the coyotes to similar cases reported in domestic and wild dogs. 
Because a competent tick vector has not yet been identified (Sen, 1933; Datta, 1941; 
Yamane et aI., 1993; Higuchi et at., 1995), this study also evaluated several commonly 
occurring ticks from Oklahoma for the ability to transstadially acquire B. gibsoni. 
The objectives of this study were: 
1. To evaluate the occurrence and extent of clinical disease in captive-raised 
coyotes following experimental infection via intravenous needle passage ofwhole 
blood infected with a canine B. gibsoni isolate from Oklahoma. 
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2. To compare the occurrence and clinical extent of disease produced by the 
experimental B. gibsoni infection in coyotes to the disease previously reported in 
mixed-breed dogs experimentally infected with the Oklahoma isolate, dogs naturally 
and experimentally infected with the California isolate, and coyotes and coydogs 
experimentally infected with an uncharacterized isolate from New England. 
3. To evaluate the vector competence of three species ofticks (Amblyomma 
americanum, Dermacentor variabilis, and Rhipicephalus sanguineus) for transstadial 
acquisition of an Oklahoma isolate ofB. gibsoni by microscopic examination of 
salivary glands. 
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CHAPTER II 
Materials and Methods 
Agent 
The B. gibsoni isolate used in this study was obtained from a nine-month-old 
male American Staffordshire Terrier (AST) from Central Oklahoma (source dog) that 
had been naturally infected with B. gibsoni. Prior to initiating the experimental blood 
transfer study, blood from the source dog was tested by enzyme-linked immunosorbent 
assay (ELISA) for Ehrlichia canis and Rocky Mountain Spotted Fever (RMSF, 
Rickettsia rickettsii) antibodies at the Oklahoma Animal Disease Diagnostic Laboratory 
(Stillwater, Oklahoma, USA) via the Pan-bio INDX dipstick (Columbia, Maryland, 
USA). The blood was also tested for heartworm (Dirofilaria immitis) antigen via 
immunoassay (Snap® test, IDEXX, Westbrook, Maine, USA). Diff-Quik® (Dade 
Behring, Duluth, Georgia, USA) stained blood films were examined microscopically 
and the polymerase chain reaction (PCR) was performed to verify infection with B. 
gibsoni. For PCR, primers that amplify most of the 18S rRNA gene from the order 
Piroplasmorida were used (Kocan et al., 2001). DNA was extracted from 200!l1 of 
whole blood with the QIAamp Blood Kit (Qiagen Inc., Valencia, California, USA) 
according to manufacture's instructions. PCR amplification was performed as 
previously described by Kocan et al. (2001). The sequence ofthe forward primer 
(BHI-NSSRNA-) was 5'-GTCAGGATCCTGGTTGATCCTGCCAG-3' and that of the 
reverse primer (ERI-NSSRNA-3-2) was 5'­
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GACTGAATTCGACTTCTCCTTCCTTTAAG-3'. The positive control reactions used 
DNA isolated from whole blood known to carry an Oklahoma isolate ofB. gibsoni. 
The negative control was distilled, deionized water. PCR products were purified using 
the Qiagen, QIAquick PCR Purification Kit and sequenced at the Oklahoma State 
University RecombinantJDNA Protein Research Facility (Stillwater, OK, USA) using a 
373 A automated DNA sequencer (Applied Biosystems, Foster City, California, USA). 
Experimental Animals 
Three male and 3 female wild-caught five-month-old coyotes were used in the 
present study. The coyotes were obtained at 3 weeks ofage by United States 
Department of Agriculture Animal Control personnel and maintained in captivity. 
Animals were housed in shaded outdoor cement runs at the Wild Animal Research 
Facility, Oklahoma State University College of Veterinary Medicine (Stillwater, 
Oklahoma, USA) and observed daily for changes in attitude, appetite, and body 
condition. Coyotes were fed dry and canned commercial dog food and water was 
available ad libitum. Tick control was maintained through monthly application of 
fipronil (Frontline®, Merial, Iselin, New Jersey, USA). All coyotes were tested by 
ELISA (Pan-bio INDX, Columbia, Maryland, USA) for E. canis and RMSF and Diff­
Quik® stained blood films were examined microsc'opically for blood-borne parasites. 
Exposure ofCoyotes to Babesia gibsoni 
Whole blood was collected from the source dog via the jugular vein and stored 
in tubes containing potassium EDTA. Within 3 hours of the blood collection, the six 
coyotes were sedated via intramuscular injection with a combination of 4 mglkg 
ketarnine HCI (KetaVed, Vedco Inc., St. Joseph, Missouri, USA) and 2 mglkg xylazine 
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(TranquiVed, Vedco Inc., St. Joseph, Missouri, USA) (Kreeger et aI., 2002). During 
sedation, physical exams were performed and urine, whole blood and serum were 
collected from each coyote. Four coyotes (two male, two female) were then each 
inoculated intravenously with 3 ml of blood from the AST containing a total of 
approximately 1xl06 B. gibsoni organisms. The two remaining coyotes (one male, one 
female) served as uninfected controls and received no parasitemic blood. 
Evaluation ofCoyotes for Clinical Disease 
Animals were sedated weekly for the rust eight weeks and then monthly until 
20 weeks post-inoculation in order to measure body mass, perform physical 
examinations, and coHect urine, whole blood and serum. Complete blood counts 
(CBC) were performed on an automated hematology unit (CellDyn 3500,. Abbott 
Diagnostics, Santa Clara, California, USA) validated for veterinary animal species and 
biochemistry panels consisting of21 values were performed on a Vitros 950 analyzer 
(OrthoClinical Diagnostics, Rochester, New York, USA). Manual white blood cell 
differential counts were performed as were manual reticulocyte counts. Manual platelet 
counts were performed when the automated count was less than 100,000/IlI. Infection 
status of B. gibsoni in coyotes was assessed using the PCR procedure described for the 
source dog as well as microscopic evaluation of Diff-Quik® stained blood films. PCR 
was performed once for each coyote at the peak of parasitemia, and stained blood films 
were examined from every sample ofblood. 
Evaluation ofTicks for Transstadial Acquisition ofBabesia gibsoni 
Amblyomma americanum, Dermacentor variabilis and Rhipicephalus 
sanguineus nymphs were obtained from the Oklahoma State University Department of 
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Entomology Tick Laboratory (Stillwater, Oklahoma, USA). Nymphs of each ofthe 3 
tick species were placed under a stockinette between the shaved shoulder blades of a 
male coyote previously infected with B. gibsoni. To confme the ticks and minimize 
escape the stockinette was placed over the torso of the coyote and secured with one­
inch porous tape. The stockinette was removed within two days. The coyote was 
housed in a stainless steel I_m2 cage that was placed over metal pans containing water 
and food and water were provided ad libitum. The edges of the pans were lined with 
duct tape to prevent escape of the feeding ticks as they dropped from the coyote. 
Replete nymphal ticks were collected daily for 2 weeks,. transferred into paper cartons 
and maintained in a humidity chamber (90 to 98% relative humidity at 25 C with a 14­
hour light-dark photophase) and allowed to molt. 
The study was conducted in two phases. Phase one involved microscopic 
examination of tick salivary glands stained with methyl green pyronin for rapid 
evaluation with light microscopy for evidence of B. gibsoni replication as described by 
Walker et a1. (1979). Phase two used light microscopy to further evaluate plastic­
embedded thick sections oftick salivary glands (Blouin et aI., 2002). Both of these 
procedures have been successful in detecting apicomplexan parasite development in 
tick salivary glands. 
In phase one, 100 nymphs of each species (A. americanum, D. variabilis and R. 
sanguineus) were placed on the coyote. Eleven survived collection and molting (5 
female and I male A. americanum, 1 female and 4 male R. sanguineus). In order to 
stimulate parasite development, molted ticks were placed in a stockinette cell attached 
to a shorn domestic sheep and allowed to feed for 5 days. The dorsal exoskeleton of 
7 
the ticks was removed with a razor blade and salivary glands were removed with fine 
forceps. Salivary glands were then stained with methyl green pyronin and examined 
under 1OOOX magnification with a light microscope. 
In phase two, 150 nymphs of each tick species were placed on the coyote and a 
representative sample of those that underwent molting was evaluated (18 female and 5 
male A. americanum, 1 female and 1 male D. variabilis, and 17 female and 6 male R. 
sanguineus). In order to stimulate parasite development, molted ticks were placed in a 
stockinette cell attached to a shorn domestic sheep and allowed to feed for 4 days. Ten 
adult males and females of each tick species that were not previously fed on coyotes 
served as negative controls and were also fed on the same sheep in a separate 
stockinette. The dorsal exoskeleton of the ticks was removed with a razor blade and 
salivary glands were removed with fine forceps. Salivary glands were immersed 
immediately in cold 2% glutaraldehyde (pH 7.4) in 0.1 M sodium cacodylate buffer 
(pH 7.2) and fixed at 4 C for 12 hours. Tissues were washed in buffer containing 
cacodylate, water and 10% sucrose, post-fixed in 2% cacodylate-buffered osmium 
tetroxide (pH 7.4), dehydrated in a graded series of increasing concentrations of ethyl 
alcohol, infiltrated with a 1: 1 mixture ofpropylene oxide/DER 332 for 48 hours, and 
then embedded in 100% DER 332. Embedded samples were heated at 60 C for 48 
hours and thick sections (approximately 111m) were prepared, stained for 2 minutes at 
60 C with Mallory's stain (Richardson et aI., 1960) and examined with a light 
microscope under 1OOOX magnification. 
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CHAPTER III
 
Results
 
Evaluation ofExperimental Babesia gibsoni Infection 
All four experimentally inoculated coyotes became infected with B. gibsoni and 
infection was demonstrated both by microscopic detection of piroplasms in Diff-Quik~ 
stained blood films and by PCR. Parasites were detectable on blood films as early as 1 
week post-inoculation, and persisted for at least 20 weeks. Parasitemia peaked at 3-4 
weeks (8-11 %), but remained greater than 1% for at least 10 weeks (Fig. 1). All four 
experimentally infected coyotes developed a mild elevation in temperature (1-2 F, 
weeks 4-12), pale mucous membranes (weeks 4-8), and splenomegaly (weeks 3-20). A 
positive heme reaction in the urine was noted sporadically from 3 to 16 weeks post­
inoculation. Mild depression and inappetance were recorded during weeks 3-4 in one 
male coyote. A regenerative anemia and thrombocytopenia of 4,500-21,000 plts/Ill 
(reference range: 112,000-319,000 pItS/ill) (Fig. 2) were detected and were inversely 
related to the parasitemia (Fig. 1). Packed cell volume (PCY) declined to 16.7-22.5% 
or 1.8-2.8x106RBC/f.l1 (reference range: 37-51% Of 4.6-7.0xl06RBC/f.lI); reticulocyte 
numbers peaked at 454,300-590,800/111 (15.4-28.7%) at 4-5 weeks. Three of four 
animals also became consistently neutropenic from weeks 2-8 (1,520-2,950/J.l.1, 
reference range: 3,900-9,600/J.l.l). An but one biochemistry value remained within 
normal reference ranges for domestic dogs and similar to the uninfected control 
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Figure 1. Average packed cell volume (PCY) and parasitemia (% RBC infected with 
B. gibsoni) for four coyotes experimentally infected with B. gibsoni and 
average PCY for two B. gibsoni uninfected control coyotes. 
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Figure 2.	 Average platelet count (platelets/Jll) for four coyotes experimentally 
infected with B. gibsoni and two uninfected control coyotes. 
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coyotes. There was an elevation in globulins (GLOB) during weeks 4 to 16 and weeks 
4 to 20 in two coyotes when compared to the uninfected control coyotes. The two 
uninfected coyotes remained negative for B. gibsoni and all evaluated hematologic and 
serum biochemical parameters remained within normal reference ranges for domestic 
dogs. Two exceptions were noted in GLOB and alkaline phosphatase (ALKP). Higher 
values were seen in the control coyotes. The reference range for domestic dog GLOB 
concentration is 2.5-3.4 gm/dl and the range for the uninfected coyotes was 2.6­
4.1gm1dl. Values for ALKP for domestic dogs are 20-157 ull while the range was 45­
225 u/I in the uninfected coyotes. 
Serum from the AST source dog obtained prior to the initiation of the 
experimental trials was negative for antigens to D. immitis and antibodies to E. canis. 
However a weakly reactive antibody titer (equivalent to 1:16-1:128 IFA titer) to RMSF 
was detected but was interpreted not to be indicative of active infection. Prior to 
experimental exposure, antibodies were not detected in the sera of the coyotes for E. 
canis or RMSF. Microscopic evaluation of Diff-Quik(/J) stained blood films and PCR 
analysis demonstrated that the source dog was infected with B. gibsoni and that before 
the study the organism was not detected in the coyotes. Partial sequence analysis from 
purified PCR products demonstrated that the coyotes became infected with B. gibsoni. 
Evaluation ofTicks for Transstadial Acquisition ofBabesia gibsoni 
Evaluation of salivary glands stained with methyl pyronin green with light 
microscopy showed possible evidence of replicating parasites, indicated by areas of 
diffuse staining within cells of salivary acini in 3 A. americanum and 1 R. sanguineus 
12 
female ticks (Fig. 3). Further evaluation by light microscopy of Mallory's stained 
plastic-embedded salivary glands of the 3 species ofticks showed no evidence of 
replicating parasites within the salivary glands (Fig. 4). 
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Figure 3.	 Photomicrograph ofmethyl green pyronin stained salivary glands from an 
adult female R. sanguineus tick previously fed on a B. gibsoni-infected 
coyote. The arrow indicates a suspiciou area insid a aLivary acinu . 
Magnification = 400X. 
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Figure 4.	 Photomicrograph ofMallory's stained salivary glands from an adult 
femaJe R. sanguineus tick previously fed on a B. gibsoni-infl cted. coyote. 
Various stages of cellular development and disintegration w re ob erved 
within salivary acini. No B. gibsoni organism were pre ent. 
Magnification = 400X. 
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CHAPTER IV 
Discussion 
The results of the present study demonstrated that coyotes were susceptible to 
experimental infection with B. gibsoni via blood transfer from a naturally infected 
domestic dog. Although hematological evidence of hemolytic disease was observed, 
mild clinical disease and lack ofmortality indicated that experimental infection with B. 
gibsoni did not have a significant adverse affect the health of these coyotes. 
Additionally, the long duration and high level of parasitemia suggested that coyotes 
could serve as potential reservoirs for B. gibsoni. Although B. gibsoni isa tick-borne 
parasite, in North America the tick vector(s) for it or any other small piroplasms of 
canids have yet to be identified. Although suspicious areas were observed in salivary 
acini of several ticks of different species by light microscopic evaluation of methyl 
green pyronin stained salivary glands (Fig. 3), the more specific procedure of 
evaluating plastic-embedded glands showed that these were likely areas of cells in 
various stages of development and disintegration (Fig. 4). These findings suggested 
that A. americanum and R. sanguineus may not be suitable vectors for B. gibsoni and 
support the hypothesis that a suitable tick vector may not be present in North America. 
Because only two D. variabilis ticks were evaluated, no conclusion can be drawn 
regarding this tick. Additional studies involving additional tick species and 
transmission trials are warranted to further investigate these fmdings. 
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In North America, the maintenance of the disease almost exclusively in AST 
colonies suggests that mechanical blood transfer and vertical transmission may be the 
methods for maintaining this parasite (Abu et aI., 1973; Correa, 1974; Irizarry-Rovira et 
aI., 200 I). The finding that coyotes were susceptible to infection and that they became 
subclinical while maintaining detectable parasites indicated that even without a tick 
vector, interspecies interactions could result in spread ofB. gibsoni between wild and 
domestic canids. It has been previously reported in Oklahoma that 10-14% of252 wild 
canids studied contained both domestic dog (Canis familiaris) and coyote traits and 5.6­
10.7% contained both red wolf (Canis rufus) and coyote traits (Freeman and Shaw, 
1979). While these numbers give some indication of the frequency of interspecies 
breeding, it is likely that fighting and other opportunities for blood transfer between 
species also occurs. 
An exact comparison of the clinical, hematologic and serum biochemical 
parameters evaluated in this study and in other studies ofB. gibsoni-like parasites in 
North America was difficult for several reasons. The age of the animal, concentration 
ofparasite, source and amount ofblood and route of inoculation all varied between 
reports, as did the length of time the animals were observed. An additional 
complication was that the same parameters were not evaluated in all animals in all 
studies. For example, concentrations of organisms were either not known (Roher et aI., 
1985; Conrad et aI., 1991) or varied from 30-530 x 106 parasites (Wozniak et at, 1997; 
Meinkoth et aI., 2002). The source of the parasite-isolate varied from unknown, to 
cryopreserved passaged blood to inoculates collected directly from an infected dog. 
Additionally, in some cases, the source dog had been treated for the infection and in 
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other cases it had not. Volume of blood inoculated ranged from 0.5-5.0 ml or was 
unknown. Routes of infection were either not known for the natural infections or were 
intravenous, subcutaneous, intraperitoneal or a combination ofmethods. With the 
exception of the naturally infected dogs for which length of observation vanes, 
experimentally infected nonsplenectomized canines were studied from 3-28 weeks. 
Generally, the clinical response of coyotes to B. gibsoni infection in the present 
study was similar to the disease produced in mixed-breed dogs (Meinkoth et aI., 2002) 
and coyotes and coydogs (Roher et aI., 1985) but relatively mild in comparison to that 
reported in dogs infected with the California B. gibsoni-hke organism (Conrad et aI., 
1991; Wozniak et aI., 1997). The present study and the four previously conducted 
studies all reported a regenerative response to the hemolytic anemia due to B. gibsoni 
infection. Evidence of a regenerative response was found by observing some or all of 
the following: reticulocytosis, polychromasia, anisocytosis, or nucleated red blood 
cells. With the exception of the California isolate, platelet counts declined within the 
first 2 weeks, then parasitemia peaked and PCV declined 3-5 weeks post-inoculation. It 
is difficult to obtain time-related data from the California isolate studies because 
Wozniak et al. (1997) only reported parasitemia at 21 and 23 days, and the study by 
Conrad et at. (1991) discussed natural infections for, which time of infection was 
unknown. 
Mixed-breed dogs experimentally infected with B. gibsoni and monitored for 28 
weeks exhibited clinical signs of anorexia, depression, fever and pale mucous 
membranes (Meinkoth et aI., 2002). Parasitemia ranged from 1.9-6.0% and remained at 
or above 1% for 2-3 weeks.. A nadir in PCV occurred at 4-5 weeks and was within 
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nonnal reference range by 1.4 weeks. The dogs initially developed a thrombocytopenia 
returned to nonnallimits by 18 weeks post-infection. A neutropenia developed in the 
6-month-old mixed-breed dogs, but not in the adults. 
Although the 2 adult mixed-breed dogs experimentally infected with the 
California B. gibson i-like organism in Wozniak et at (1997) were only followed for 22 
days before being splenectomized, 2 dogs naturally infected were also included in the 
study. Both of these dogs were euthanized due to severe illness. Wozniak reported 
splenomegaly and hemoglobinuria, as well as a decreased mean PCV (19%) and 
thrombocytopenia (32,000/111). The 2 experimentally infected dogs had peak 
parasitemias at day 21 (0.9%) and day 23 (3.7%) post-inoculation. Neutrophil counts 
remained within nonnallimits, and elevations in alkaline phosphatase (ALP), aspartate 
aminotransferase (AST), alanine phosphatase (ALT) and bilirubin were noted. 
Hypoalbuminemia also occurred. 
Eleven dogs naturally infected with the California B. gibsoni-like isolate 
developed a regenerative response to the anemia caused by the parasite, but many 
developed severe illness (Conrad et aL, 1991). Clinical symptoms were complicated by 
the disease affecting other organs such as the liver or kidneys. Vomiting and icterus 
were described and recrudescence of the disease w~s observed. Parasitemia peaked at 
40% (5-40%), and a decreased PCV (9-16%) and thrombocytopenia (aU < 80,000/lll) 
also occurred. Neutropenia was observed in some young dogs while neutrophilia 
occurred in some adult dogs. Dogs were followed various lengths of time and some 
were lost to follow-up. Six of the 11 cases in Conrad's study died or were euthanized. 
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The higher level of parasitemia and recrudescence of the disease, coupled with the 
mortality and morbidity indicate that the California organism may be more virulent. 
Experimental infection of 6 adult coyotes and 2 adult coydogs inoculated with 
the uncharacterized Babesia spp. isolate from New England (Roher et at, 1985), 
resulted in anorexia, splenomegaly and a parasitemia that ranged from 1-11.5%. A 
nadir in PCV (16%) and peak parasitemia (11.5%) occurred at 4 weeks, and elevations 
in bilirubin and globulins were noted. Dark, red-brown urine was also reported. 
Neutrophil counts remained within nonnal limits. The coyotes and coydogs were 
followed anywhere from 3.5 to 16 weeks. 
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CHAPTER V 
Summary and Conclu_sions 
The discovery that coyotes, a widely distributed and commonly occurring wild 
canid, are susceptible to infection with B. gibsoni coupled with the recent entry and 
establishment ofthis parasite in domestic dogs in North America demonstrates the role 
of coyotes as a potential wildlife reservoir for this parasite. The observed clinical 
response suggested that coyotes would likely be a competent wildlife reservoir ifB. 
gibsoni were to enter wild canids because they maintained a high parasitemia for a long 
duration while developing a mild clinical disease with no mortality. These findings 
also support the need for more stringent evaluation of canines entering into and 
traveling between states in the United States. Although quarantine periods are 
beneficial, complete physical exams and microscopic evaluation of stained blood films 
should also be performed to reduce the risk ofthis or another foreign animal disease 
entering the United States. 
In the present study, the clinical disease produced by B. gibsoni in coyotes was 
similar to the disease previously reported in mixed-breed dogs, coyotes and coydogs 
experimentally infected with the same organism and an uncharacterized isolate from 
New England. In contrast, the disease that was reported in naturally and experimentally 
infected mixed-breed dogs with a California B. gibsoni-like isolate was more severe. 
We were unable to confirm that any of three common North American ticks (A. 
americanum, D. variabilis and R. sanguineus) couid acquire B. gibsoni following 
21 
feeding on an infected coyote, but further studies are warranted to determine the 
potential role of ticks in maintaining and transmitting this parasite in North America. 
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Appendix 1·Selected hematologic and urologic parameters for coyotes. 
#188: Experimentally infected coyote: intact male 
Parameter 
RBC 
HGB 
PCV 
PlT 
RETIC 
RETIC 
nRBC 
(units) 
(XlO"lfll.) 
(g/dl.) 
(%) 
(Plt/fll) 
(%) 
(reticlfll) 
(nRBCI100 WBC) 
9/25/2001 
DAVO 
4.74 
11.1 
35.5 
236.000 
2.1 
99,540 
0 
10/212001 
1WK 
4.93 
11.5 
35.7 
137.000 
2.7 
133.110 
0 
1019/2001 
2WK 
2.75 
6.48 
19.8 
4,500 
2.4 
66.000 
1 
1011612001 
3WK 
2.12 
5.37 
17.2 
28,500 
13.7 
290.440 
12 
1012312001 
4WK 
1.93 
5.14 
16.7 
72,500 
16.6 
320,380 
6 
10130/2001 
5WK 
2.15 
5.74 
19.2 
38,000 
16.7 
359,050 
6 
111612001 
6WK 
2.76 
6.93 
23.3 
24,000 
15.5 
427,800 
18 
11/1312001 
7WK 
2.95 
7.26 
24.2 
30,500 
15.4 
454,300 
18 
11/2012001 
8WK 
3.2 
7.67 
25.4 
24,500 
6 
192,000 
3 
1211812001 
12WK 
4.89 
11.3 
35.8 
42,500 
1.7 
83.130 
3 
1/1512002 
16WK 
4.51 
10.9 
34.2 
111,000 
3.8 
171,380 
6 
211212002 
20WK 
5.23 
12.4 
38.4 
52,500 
0.6 
31,380 
0 
PARASITEMIA (%) 0 <1 4 10 8 6 6 5 4 1 <1 <1 
V\lBC 
NEUT 
(WBC/lll) 
(neuVlll) 
11,500 
6,120 
7.340 
3,700 
4,770 
2,190 
8.880 
2.160 
3,440 
1,600 
4,550 
2.800 
3,300 
1.520 
3,330 
2,460 
3,320 
1.560 
10,800 
4.230 
6,890 
4,400 
10.300 
4,620 
N 
-...l 
BUN 
lDH 
Bill 
PROT 
GLOB 
AlKP 
AlT 
ALB 
(mgtdl) 
(U/l) 
(mgldl) 
(grnldl.) 
(grnldl) 
(Ull) 
(Ull) 
(grnldl) 
8 
1227 
0.2 
6.1 
3.8 
147 
23 
2.3 
15 
43 
0.3 
5.8 
3.5 
156 
26 
2.3 
15 
690 
0.1 
5.3 
3.3 
90 
13 
2 
10 
555 
0.2 
5.9 
3.8 
75 
14 
2.1 
11 
733 
0.1 
6.1 
3.9 
66 
14 
2.2 
15 
441 
0.1 
6.1 
3.8 
78 
16 
2.3 
21 
334 
0.1 
6 
3.7 
87 
12 
0.6 
15 
568 
0.1 
6.2 
3.8 
73 
16 
0.6 
12 
817 
0.1 
6 
3.7 
76 
26 
2.3 
13 
271 
0.1 
5.7 
3 
85 
33 
2.7 
16 
160 
0.1 
5.8 
3 
54 
34 
2.8 
20 
182 
0.1 
5.5 
2.8 
57 
39 
2.8 
Heme in urine (mgldL HGB 0( MGB 
or SolO RBC/IJL) 
nd­ nd nd mod-lg nd nd sm-mod mod nd mod trace nd 
nd" no data 
Appendix l-Selected hematologic and urologic parameters for coyotes. 
#191: Experimentally infected coyote; intact maJe 
Parameter 
RBG 
HGB 
PCV 
PlT 
RETIC 
RETIC 
nRBC 
(units) 
(X10'/IJL) 
(g1dl) 
(%) 
(pIVIJL) 
(%) 
(reticJlJl) 
(nRBC/100 waC) 
9/2512001 
DAY 0 
5.65 
12.9 
41.5 
234,000 
1,1 
62,150 
0 
10/212001 
1 WK 
5.17 
12.2 
37.2 
82,400 
26 
134,420 
0 
10/9/2001 
2WK 
5.15 
12 
37.1 
13,100 
3.1 
159,650 
1 
10/16/2001 
3WK 
3.13 
7.7 
23.7 
36,500 
7.4 
231,620 
2 
10/23/2001 
4WK 
2.8 
7.14 
22.5 
48,500 
21.1 
590,800 
36 
10/30/2001 
5WK 
3.11 
7.91 
25.9 
58,500 
13.1 
407,410 
74 
11/6/2001 
6WK 
3.15 
8.11 
25.9 
32,500 
13.8 
434,700 
27 
11/1312001 
7 WI< 
3.55 
9.01 
29 
22,500 
20,7 
734,850 
35 
11/20/2001 
8 WI< 
3.4 
8.51 
27.5 
17,500 
10.2 
346,800 
34 
12118/2001 
12WK 
4.01 
9.6 
30.3 
27,000 
3.2 
128,320 
7 
1/15/2002 
16WK 
4.8 
11.4 
36.7 
84,500 
2 
96,000 
6 
211212002 
20WK 
5.41 
12.9 
40.4 
103,000 
3.9 
210,990 
1 
PARASITEMIA (%) 0 <1 2 3 11 5 6 5 5 1 <1 <1 
wac 
NEUT 
(WBC/IJL) 
(neuVIJL) 
8,730 
4,980 
7,730 
3,930 
6,890 
4,190 
4,810 
2.950 
6,270 
3,500 
6,120 
3,990 
5,670 
3,470 
6,980 
4,660 
11,200 
4,310 
7,880 
5.260 
7,530 
4.440 
11,200 
7,480 
IV 
00 
BUN 
lDH 
Bill 
PROT 
GLOB 
ALKP 
ALT 
ALB 
(mg/dl) 
(U/l) 
(mgIdl) 
(gmJdL) 
(gmJdL) 
(UIL) 
(Ull) 
(gmJdL) 
6 
1278 
0.2 
6.4 
3.9 
142 
25 
2,5 
12 
522 
0.1 
6 
3.6 
141 
35 
2.3 
13 
477 
0.4 
6.2 
3.5 
121 
20 
2.7 
7 
318 
0.1 
5.7 
3.6 
83 
20 
2.1 
9 
515 
0.1 
6.3 
3.9 
83 
16 
2.4 
11 
531 
0.2 
6,3 
4 
68 
18 
2.3 
25 
305 
0.2 
6.3 
3.8 
65 
13 
24 
17 
339 
0.2 
6.6 
4.1 
63 
16 
25 
11 
616 
0.1 
6.2 
3.9 
63 
23 
2.3 
15 
322 
0.2 
5.9 
3.5 
72 
16 
2,4 
9 
175 
0.1 
6.1 
3.7 
55 
21 
2.4 
10 
199 
0.1 
6.6 
4.1 
42 
28 
2.4 
Heme in urine (mgldL HGB or 1.1GB 
or SolO R8C1pl) 
nd nd nd tr nd nd mod sm-mod 19 sm-mod mod No 
nd =no data 
Appendix 1-Selected hematologic and urologic parameters for coyotes. 
#193: Experimentally infected coyote: intact female 
Parameter 
RBC 
HGB 
PCV 
PLT 
RETIC 
RETIC 
nRBC 
(units) 
(X106IIlL) 
(gldL) 
("!o) 
(pIVIlL) 
("!o) 
(retidIlL) 
(nRBC/100 WBC) 
9/25/2001 
DAY 0 
5 
12.3 
38.2 
424,000 
1.6 
79.200 
0 
101212001 
1Wl< 
5.02 
12.6 
37.9 
226,000 
1.3 
65,260 
0 
1019/2001 
2Wl< 
3.42 
8.54 
25.7 
23,500 
1.9 
64,980 
3 
10/16/2001 
3Wl< 
2.78 
7.26 
23 
45,500 
12.4 
344,720 
20 
10/23/2001 
4WK 
1.98 
5.63 
18.2 
44,500 
24.4 
483,120 
6 
10/30/2001 
5WK 
2.03 
5.7 
18.9 
52,500 
28.7 
582,610 
11 
11/612001 
6Wl< 
2.35 
6.34 
21.3 
88,000 
16.2 
380,070 
8 
11113/2001 
7Wl< 
2.68 
6.89 
23.1 
39,500 
13.8 
369,840 
4 
11/20/2001 
8Wl< 
3.14 
7.64 
26 
27,000 
11.1 
348,540 
4 
12118/2001 
12Wl< 
4.73 
10.9 
34.7 
80,OQO 
3.1 
146,630 
2 
111512002 
16WK 
5.66 
12.9 
40.5 
157,000 
1.4 
79,240 
0 
211212002 
20Wl< 
6.16 
14.3 
43.8 
122,000 
1.7 
104,720 
0 
PARASITEMIA ("!o) 0 <1 4 9 9 7 6 6 6 1 <1 <1 
wac 
NEUT 
(WBC/IlL) 
(neuVIlL) 
14.300 
8,380 
8,660 
4,600 
6,040 
2,980 
4,310 
2,080 
4,270 
2,190 
4,180 
2,340 
4,770 
2.,160 
6,010 
3,010 
5,510 
2,850 
7,800 
3,790 
11,000 
5,880 
12,900 
6,920 
tv 
\0 
BUN 
LDH 
Bill 
PROT 
GLOB 
ALKP 
ALT 
ALB 
(mgldL) 
(UIL) 
(mg/dL) 
(gmldL) 
(gmldL) 
(UIL) 
(UlL) 
(gmldL) 
8 
934 
0.1 
6.5 
4.1 
162 
24 
2.4 
14 
460 
0.3 
5.7 
3.4 
149 
25 
2.3 
15 
418 
0.2 
56 
3.3 
101 
17 
2.3 
9 
426 
0.1 
6.1 
3.9 
81 
20 
22 
13 
904 
0.1 
6.6 
4.3 
60 
15 
2.3 
10 
442 
0.2 
7.1 
4.7 
66 
14 
2.5 
16 
376 
0.2 
7.7 
5.2 
63 
9 
2.5 
21 
367 
0.2 
7.3 
4.8 
57 
13 
2.5 
15 
547 
0.1 
76 
5.1 
60 
17 
2.5 
18 
353 
0.1 
7 
4.3 
65 
19 
2.6 
12 
259 
0.1 
7.1 
4.3 
55 
29 
2.8 
9 
234 
0,1 
7.1 
4.3 
56 
35 
2.7 
Heme in urine (mgldL HGB 0< MGB 
0< $-10 RBClpL) 
-nd nd nd mod-19 nd 19 19 Ig nd mod No IN HEAT 
nd = no d.ata 
Appendix l-$elected hematologic and urologic parameters for coyotes. 
#194: Experimentally infected coyote; intact female 
Parameter 
RBC 
HGB 
PCV 
PLT 
RETlC 
RETlC 
nRBC 
(units) 
(Xl06/~L) 
(g/dL) 
("!o) 
(pIV~L)  
("!o) 
(relic/Ill) 
(nRBC/l00 WBC) 
9/25/2001 
DAY 0 
4.74 
11.9 
37.3 
361,000 
1.3 
61,620 
a 
10/212001 
1WK 
4.25 
10.7 
33 
148,000 
2.5 
106,250 
a 
10/9/2001 
2WK 
3.46 
8.61 
26.4 
21.000 
2.6 
89,960 
0 
10/1612001 
3WK 
2.32 
6.02 
18.9 
25.000 
5.7 
132,240 
16 
10/23/2001 
4WK 
1.84 
5.39 
16.7 
77,000 
12.5 
230,000 
8 
10/30/2001 
5WK 
2.51 
6.79 
22.5 
44,500 
18.9 
474,390 
13 
11/612001 
6WK 
2.88 
7.6 
25.1 
81,500 
11.5 
331,200 
13 
11/13/2001 
-
7WK 
3.24 
8.11 
26.8 
42,000 
8.2 
265.680 
8 
11/20/2001 
8WK 
3.42 
8.44 
28 
37.000 
7.9 
270,180 
8 
1211812001 
12WK 
4.48 
10.5 
33.3 
165,000 
2.3 
103,040 
2 
1/15/2002 
16WK 
5.06 
12.1 
37.8 
177,000 
2 
101,200 
1 
211212002 
20WK 
6.37 
15.1 
46.5 
361,000 
1.3 
82,810 
2 
PARASITEMIA ("!o) a "1 4 8 3 4 4 4 4 1 <1 <1 
WBC 
NEUT 
(WBC/~L)  
(neuV~l)  
17.600 
11,500 
10.100 
6,080 
6.360 
3,470 
5,260 
2.590 
6,640 
3,370 
4,330 
2,200 
4,790 
2,360 
4,680 
2,460 
4,870 
2.150 
14,000 
8.850 
10,000 
5.400 
14,300 
9,340 
w 
0 
BUN 
LDH 
Bill 
PROT 
GLOB 
ALKP 
ALT 
ALB 
(mgIdL) 
(U/L) 
(mgldL) 
(gmldL) 
(gmldL) 
(U/L) 
(UlL) 
(gmldL) 
13 
621 
0.1 
7.2 
4.8 
171 
57 
2.4 
10 
355 
0.1 
62 
4.1 
138 
52 
2.1 
16 
359 
0.1 
6.1 
3.7 
90 
32 
VI 
9 
356 
0.1 
5.8 
3.8 
85 
28 
2 
10 
1418 
0.1 
6.2 
4.3 
71 
20 
2 
10 
356 
0.1 
6.4 
4.4 
91 
20 
2,1 
31 
247 
0.1 
6.4 
4.3 
94 
14 
2.2 
19 
312 
0.1 
6.5 
4.2 
83 
24 
2.3 
17 
575 
0.1 
6.6 
4.2 
73 
31 
2.4 
10 
312 
0.1 
6 
4.5 
84 
28 
2.6 
11 
161 
0.1 
6.7 
4.2 
56 
31 
2.6 
11 
181 
0.2 
5.8 
3.2 
38 
29 
2.6 
Heme in u.rine (mgldL HGB or 101GB 
or $010 RE!C/}JL! 
nd nd nd nd nd sm mod nd sm tr-sm IN HEAT IN HEAT 
nd = no data 
Appendix 1-Selected hematologic and urologic parameters for coyotes. 
#189: Uninfected control coyote: intact female 
Parameter 
RBC 
HGB 
PCV 
PlT 
RETIC 
RETIC 
nRBC 
(units) 
(Xl0·/IJL) 
(g/dL) 
(%) 
(pItIlJl) 
(%) 
(raticllJl) 
(nRBC/l00 INBC) 
9/25/2001 
DAVO 
5.49 
12.8 
40.7 
307.000 
1.7 
93,330 
a 
10/212001 
1 WK 
5.6 
13.4 
40.8 
315,000 
1.1 
61,600 
0 
10/9/2001 
2WK 
5.69 
13.4 
41 
315.000 
2.1 
119,490 
0 
10/1612001 
3WK 
6.02 
14.2 
43.7 
135.000 
1.3 
78,260 
a 
101i3J2001 
4WK 
5.89 
14 
43.1 
282,000 
1 
58,900 
0 
1(J/30/2001 
5WK 
6,08 
14.5 
44.2 
316,000 
0.5 
30,400 
0 
11/6/2001 
6WK 
6.07 
14.4 
44 
277,000 
0.4 
24,280 
2 
11/13/2001 
7WK 
6.13 
14.6 
44.4 
297,000 
0.7 
42,910 
0 
11/20/2001 
8WK 
6.34 
15 
46.3 
264.000 
0.4 
25.360 
6 
12/1ll/2001 
12WK 
6.9 
16.3 
50.3 
296,000 
0.2 
13,800 
0 
1/15/2002 
16WK 
7 
17 
51.1 
291,000 
0.6 
112,000 
0 
2/1212002 
20WK 
e.6 
15.6 
48.1 
319,000 
1 
66,000 
0 
PARASITEMIA (%) a a a a 0 0 0 0 0 0 a 0 
\NBC 
NEUT 
(INBC/lJl) 
(neuUIJL) 
9,220 
4.970 
10.500 
7,310 
9.050 
5.770 
7.880 
5,100 
7,540 
4,670 
7,190 
4,260 
8,990 
5,170 
9,320 
5,260 
8,010 
5,100 
7,810 
5.470 
6.060 
3,920 
8,230 
5,630 
w
-
BUN 
LDH 
Bill 
PROT 
GLOB 
ALKP 
ALT 
ALB 
(mg/dL) 
(U/L) 
(mgidL) 
(gmidL) 
(gmidL) 
(U/l) 
(U/l) 
(gmidl) 
12 
868 
0.1 
6.4 
3.7 
143 
23 
2.7 
13 
773 
0.3 
6.3 
3.7 
150 
21 
2.6 
11 
332 
0.1 
6 
3.2 
114 
22 
2.7 
10 
338 
0.1 
6.1 
3.3 
108 
31 
2.8 
12 
447 
0.1 
6.1 
3.3 
103 
30 
2.8 
14 
352 
0.1 
6.2 
3.3 
109 
27 
2.9 
15 
180 
0,1 
6.1 
3.2 
89 
24 
29 
19 
392 
0.2 
6.1 
3.2 
83 
24 
2.9 
11 
883 
0.1 
6.1 
3.2 
74 
33 
2.9 
14 
284 
0.1 
6.1 
3.2 
56 
29 
2.9 
14 
263 
0.1 
5.4 
2.6 
45 
liS 
2.8 
14 
229 
0.2 
5.8 
3.1 
46 
39 
2.7 
Heme in urine (mgldL HGB or 1.1GB 
or SolO RBClIllJ 
nd nd nd No nd nd No No No No No No 
nd = no data 
Appendix 1-Selected hematologic and urologic parameters for coyotes. 
#190: Uninfeded control coyote; intact male 
Parameter 
RBC 
HGB 
PCV 
PLT 
RETlC 
RETIC 
nRBC 
(units) 
(X10·/~L) 
(gldL) 
("!o) 
(p1U~L)  
('Ill) 
(reticl~L)  
(nRBC/100 VVBC) 
9/2512001 
DAY 0 
4.56 
11.5 
37.6 
36,000 
1,9 
86,640 
0 
101212001 
1WK 
4.98 
12.6 
398 
112,000 
1.3 
64,740 
0 
10/9/2001 
2WK 
4.68 
12 
36.7 
179,000 
2 
93,600 
0 
10/16/2001 
3WK 
4.98 
12.4 
39.7 
179,000 
1.1 
54,760 
0 
10/23/ioOl 
4WK 
4.89 
12.3 
38.6 
162,000 
1.4 
68,460 
0 
10/3012001 
5 WI< 
5.3 
13.5 
41.2 
192,000 
2,2 
116,600 
0 
11/612001 
6WK 
4.76 
12 
36.9 
175,000 
1.5 
71,400 
1 
11/13/2001 
7WK 
5.42 
13.7 
42 
247,000 
1.2 
65,040 
0 
11/20/2001 
8 WI< 
5.11 
12.9 
39.8 
204,000 
2.4 
122,640 
0 
12118/2001 
12 WI< 
5.39 
13.6 
41.3 
235,000 
1.2 
64,680 
0 
1/15/2002 
16 WI< 
6.4 
16.1 
50.1 
250,000 
0.9 
57,600 
0 
211212002 
20WK 
6.3 
16.1 
49.1 
177,000 
1.1 
69,300 
0 
PARASITEMIA ('Ill) 0 0 0 0 0 0 0 0 0 0 0 0 
WBC 
NEUT 
(WBC/~L)  
(neutl~L)  
8,710 
5,520 
12,300 
9,560 
11.000 
8,110 
6,640 
4,510 
9,820 
6,500 
8,600 
6,080 
7,370 
4,310 
9,330 
6,680 
9,690 
6,840 
10,000 
6,510 
8,710 
5,950 
10,900 
7,230 
V.l 
N 
BUN 
LDH 
Bill 
PROT 
GLOE! 
ALKP 
ALT 
ALB 
(mgldL) 
(U/L) 
(mgldL) 
(gmJdL) 
(gmJdL) 
(U/L) 
(U/L) 
(9m1dL) 
8 
555 
0.1 
6.5 
4.1 
19<4 
25 
2.4 
17 
912 
0.5 
6.5 
4 
225 
26 
2.5 
19 
656 
0.3 
6.3 
3.4 
19<4 
22 
2.9 
17 
328 
0,1 
5.9 
3.2 
197 
31 
2.7 
13 
376 
0.3 
5.8 
3 
ln 
26 
2.8 
20 
301 
0.1 
6 
3.1 
177 
29 
2.9 
19 
709 
0.1 
5.6 
3 
133 
27 
2.6 
26 
478 
0.2 
5.9 
3.1 
140 
32 
2.8 
17 
519 
0.1 
5.7 
3 
132 
33 
2.8 
15 
264 
0.1 
5.4 
2,8 
108 
33 
2.6 
24 
258 
0.1 
5.6 
2.7 
91 
33 
2.9 
21 
427 
0.3 
5.9 
2,9 
71 
34 
3 
Heme in urine (mg/dL HGB 0( MOB 
or 5-10 RBCI\IL) 
nd nd nd No nd nd No No No No No No 
nd =no data 
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